{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:40:30Z","timestamp":1790005230277,"version":"4.0.1"},"reference-count":74,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Department of Science and Technology\u2014Philippine Council for Health Research and Development"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>HPV infection is one of the most studied risk factors in cervical cancer\u2014the second most common cancer site and cause of death due to cancer in the Philippines. However, there is a lack of population-based epidemiological data on cervical HPV infection in the Philippines. Local reports on co-infections with other lower genital tract pathogens, commonly reported globally, are also lacking, which emphasizes the need to increase efforts in targeting HPV prevalence, genotype, and distribution. Hence, we aim to determine the molecular epidemiology and natural history of HPV infection among reproductive-age Filipino women using a community-based prospective cohort design. Women from rural and urban centers will be screened until the target sample size of 110 HPV-positive women (55 from rural sites and 55 from urban sites) is reached. Cervical and vaginal swabs will be collected from all screened participants. For HPV-positive patients, HPV genotypes will be determined. One hundred ten healthy controls will be selected from previously screened volunteers. The cases and controls will comprise the multi-omics subset of participants and will be followed up after 6 and 12 months for repeat HPV screening. Metagenomic and metabolomic analyses of the vaginal swabs will also be performed at baseline, after 6 months, and after 12 months. The results of this study will update the prevalence and genotypic distribution of cervical HPV infection among Filipino women, determine whether the current vaccines used for HPV vaccination programs capture the most prevalent high-risk HPV genotypes in the country, and identify vaginal community state types and bacterial taxa associated with the natural history of cervical HPV infection. The results of this study will be used as the basis for developing a biomarker that can help predict the risk of developing persistent cervical HPV infection in Filipino women.<\/jats:p>","DOI":"10.3390\/healthcare11050658","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T03:57:35Z","timestamp":1677211055000},"page":"658","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Determinants of Acquisition, Persistence, and Clearance of Oncogenic Cervical Human Papillomavirus Infection in the Philippines Using a Multi-Omics Approach: DEFEAT HPV Study Protocol"],"prefix":"10.3390","volume":"11","author":[{"given":"Sheriah Laine M.","family":"de Paz-Silava","sequence":"first","affiliation":[{"name":"Multi-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines"},{"name":"Department of Medical Microbiology, College of Public Health, University of the Philippines Manila, Manila 1000, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0956-334X","authenticated-orcid":false,"given":"Ian Kim B.","family":"Tabios","sequence":"additional","affiliation":[{"name":"Multi-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines"},{"name":"Department of Biochemistry and Molecular Biology, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines"},{"name":"Institute of Biology, College of Science, University of the Philippines Diliman, Quezon City 1101, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4535-8837","authenticated-orcid":false,"given":"Ourlad Alzeus G.","family":"Tantengco","sequence":"additional","affiliation":[{"name":"Multi-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines"},{"name":"Department of Physiology, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines"},{"name":"Department of Biology, College of Science, De La Salle University, Manila 0922, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fresthel Monica M.","family":"Climacosa","sequence":"additional","affiliation":[{"name":"Multi-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines"},{"name":"Department of Medical Microbiology, College of Public Health, University of the Philippines Manila, Manila 1000, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7727-2838","authenticated-orcid":false,"given":"Clarissa L.","family":"Velayo","sequence":"additional","affiliation":[{"name":"Multi-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines"},{"name":"Department of Physiology, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines"},{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of the Philippines College of Medicine\u2014Philippine General Hospital, University of the Philippines Manila, Manila 1000, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7192-2377","authenticated-orcid":false,"given":"Ryan C. V.","family":"Lintao","sequence":"additional","affiliation":[{"name":"Multi-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6089-9861","authenticated-orcid":false,"given":"Leslie Faye T.","family":"Cando","sequence":"additional","affiliation":[{"name":"Multi-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8334-0224","authenticated-orcid":false,"given":"Glenmarie Angelica S.","family":"Perias","sequence":"additional","affiliation":[{"name":"Multi-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel C.","family":"Idolor","sequence":"additional","affiliation":[{"name":"Multi-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abialbon G.","family":"Francisco","sequence":"additional","affiliation":[{"name":"Multi-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines"},{"name":"Department of Medical Microbiology, College of Public Health, University of the Philippines Manila, Manila 1000, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3152-8484","authenticated-orcid":false,"given":"Charlene Divine M.","family":"Catral","sequence":"additional","affiliation":[{"name":"Multi-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte M.","family":"Chiong","sequence":"additional","affiliation":[{"name":"Multi-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines"},{"name":"Department of Otolaryngology\u2014Head and Neck Surgery, University of the Philippines College of Medicine\u2014Philippine General Hospital, Manila 1000, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie Michele M.","family":"Dalmacio","sequence":"additional","affiliation":[{"name":"Multi-Omics Research Program for Health, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines"},{"name":"Department of Biochemistry and Molecular Biology, College of Medicine, University of the Philippines Manila, Manila 1000, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"key":"ref_1","unstructured":"Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J., Gomez, D., Munoz, J., Bosch, F.X., and de Sanjose, S. (2021). Human Papillomavirus and Related Diseases in the World. Summary Report 22 October 2021, ICO\/IARC Information Centre on HPV and Cancer (HPV Information Centre)."},{"key":"ref_2","unstructured":"Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J., G\u00f3mez, D., Mu\u00f1oz, J., Bosch, F., and de Sanjos\u00e9, S. (2021). Human Papillomavirus and Related Diseases in United States of America. Summary Report 22 October 2021, ICO\/IARC Information Centre on HPV and Cancer (HPV Information Centre)."},{"key":"ref_3","unstructured":"Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J.J., Gomez, D., Mu\u00f1oz, J., Bosch, F.X., and de Sanjos\u00e9, S. (2021). Human Papillomavirus and Related Diseases in China. Summary Report 22 October 2021, ICO\/IARC Information Centre on HPV and Cancer (HPV Information Centre)."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/cncr.30947","article-title":"Five-Year Relative Survival for Human Papillomavirus-Associated Cancer Sites","volume":"124","author":"Razzaghi","year":"2018","journal-title":"Cancer"},{"key":"ref_5","unstructured":"Cancer Statistics Working Group U.S. (2022, October 01). Cancer Statistics Data Visualizations Tool, Based on 2021 Submission Data (1999\u20132019): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Available online: https:\/\/www.cdc.gov\/cancer\/uscs\/dataviz\/index.htm."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ejogrb.2021.07.053","article-title":"Human Papillomavirus (HPV) in Pregnancy\u2014An Update","volume":"264","author":"Chilaka","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_8","unstructured":"Laudico, A.V., Mirasol-Lumague, M.R., Medina, V., Mapua, C.A., Valenzuela, F.G., and Pukkala, E. (2015). Philippine Cancer Facts and Estimates, Philippine Cancer Society. Available online: https:\/\/www.philcancer.org.ph\/images\/pdf\/data\/2010-Philippine-Cancer-Facts-Estimates.pdf."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","article-title":"Prevalence of Human Papillomavirus in Cervical Cancer: A Worldwide Perspective","volume":"87","author":"Bosch","year":"1995","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jnci\/90.1.43","article-title":"Causes of Cervical Cancer in the Philippines: A Case-Control Study","volume":"90","author":"Ngelangel","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/ewjm.175.4.231","article-title":"Cervical Cancer in the Developing World","volume":"175","author":"Sherris","year":"2001","journal-title":"West. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12905-015-0231-0","article-title":"Socio-Economic and Cultural Vulnerabilities to Cervical Cancer and Challenges Faced by Patients Attending Care at Tikur Anbessa Hospital: A Cross Sectional and Qualitative Study","volume":"15","author":"Tadesse","year":"2015","journal-title":"BMC Womens Health"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human Papillomavirus Is a Necessary Cause","volume":"189","author":"Walboomers","year":"1999","journal-title":"J. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","article-title":"Human Papillomavirus and Cervical Cancer","volume":"16","author":"Burd","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"11451","DOI":"10.1128\/JVI.78.21.11451-11460.2004","article-title":"Mechanisms of Human Papillomavirus-Induced Oncogenesis","volume":"78","author":"Baldwin","year":"2004","journal-title":"J. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1086\/338010","article-title":"Determinants of Cervical Human Papillomavirus Infection: Differences between High-and Low-Oncogenic Risk Types","volume":"185","author":"Chan","year":"2002","journal-title":"J. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00006250-199203000-00002","article-title":"Human Papillomavirus Infection of the Cervix: Relative Risk Associations of 15 Common Anogenital Types","volume":"79","author":"Lorincz","year":"1992","journal-title":"Obstet. Gynecol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/1743-422X-8-269","article-title":"Oncogenic Potential of Human Papillomavirus (HPV) and Its Relation with Cervical Cancer","volume":"8","author":"Faridi","year":"2011","journal-title":"Virol. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.biopha.2014.12.041","article-title":"Overview of High-Risk HPV\u2019s 16 and 18 Infected Cervical Cancer: Pathogenesis to Prevention","volume":"70","author":"Ramakrishnan","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"10515","DOI":"10.1128\/JVI.00731-09","article-title":"Tissue-Spanning Redox Gradient-Dependent Assembly of Native Human Papillomavirus Type 16 Virions","volume":"83","author":"Conway","year":"2009","journal-title":"J. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3802\/jgo.2009.20.1.11","article-title":"Epidemiology, Prevention and Treatment of Cervical Cancer in the Philippines","volume":"20","author":"Domingo","year":"2009","journal-title":"J. Gynecol. Oncol."},{"key":"ref_22","first-page":"e2020071","article-title":"Cervical Cancer Screening in Low-Income Countries: A Report on the Implementation of Cervical Screening in Luzon, Philippines","volume":"4","author":"Carr","year":"2020","journal-title":"J. Glob. Heal. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.3389\/fmed.2022.929062","article-title":"Current Status of Human Papillomavirus Infection and Cervical Cancer in the Philippines","volume":"9","author":"Lintao","year":"2022","journal-title":"Front. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.31557\/APJCP.2019.20.7.2103","article-title":"Association of PIK3CA and MDM2 SNP309 with Cervical Squamous Cell Carcinoma in a Philippine Population","volume":"20","author":"Tantengco","year":"2019","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_25","unstructured":"Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J., G\u00f3mez, D., Mu\u00f1oz, J., Bosch, F.X., and de Sanjos\u00e9, S. (2021). Philippines: Human Papillomavirus and Related Diseases Report, ICO\/IARC Information Centre on HPV and Cancer (HPV Information Centre)."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0140-6736(20)30068-4","article-title":"Impact of HPV Vaccination and Cervical Screening on Cervical Cancer Elimination: A Comparative Modelling Analysis in 78 Low-Income and Lower-Middle-Income Countries","volume":"395","author":"Brisson","year":"2020","journal-title":"Lancet"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.jcv.2015.11.020","article-title":"Cervical Cancer Screening of HPV Vaccinated Populations: Cytology, Molecular Testing, Both or None","volume":"76","author":"Richardson","year":"2016","journal-title":"J. Clin. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-020-01538-9","article-title":"Screening for the Prevention and Early Detection of Cervical Cancer: Protocol for Systematic Reviews to Inform Canadian Recommendations","volume":"10","author":"Gates","year":"2021","journal-title":"Syst. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.17352\/jgro.000045","article-title":"Screening and Prevention of Cervical Cancer in the World","volume":"3","year":"2017","journal-title":"J. Gynecol. Res. Obstet."},{"key":"ref_30","unstructured":"World Health Organization (2014). Comprehensive Cervical Cancer Control: A Guide to Essential Practice, World Health Organization. [2nd ed.]."},{"key":"ref_31","unstructured":"World Health Organization (2021). WHO Guideline for Screening and Treatment of Cervical Pre-Cancer Lesions for Cervical Cancer Prevention, World Health Organization. [2nd ed.]."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4103\/0971-5851.92808","article-title":"An Overview of Prevention and Early Detection of Cervical Cancers","volume":"32","author":"Mishra","year":"2011","journal-title":"Indian J. Med. Paediatr. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"744","DOI":"10.5306\/wjco.v5.i4.744","article-title":"Update on prevention and screening of cervical cancer","volume":"5","author":"McGraw","year":"2014","journal-title":"World J. Clin. Oncol."},{"key":"ref_34","first-page":"471","article-title":"Primary study on the relationship between high-risk HPV infection and vaginal cervical microbiota","volume":"53","author":"Zhang","year":"2018","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Guerrero, A.M., Genuino, A.J., Santillan, M., Praditsitthikorn, N., Chantarastapornchit, V., Teerawattananon, Y., Alejandria, M., and Toral, J.A. (2015). A Cost-Utility Analysis of Cervical Cancer Screening and Human Papillomavirus Vaccination in the Philippines. BMC Public Health, 15.","DOI":"10.1186\/s12889-015-2046-1"},{"key":"ref_36","unstructured":"World Health Organization (2021). Cervical Cancer Country Profiles, World Health Organization."},{"key":"ref_37","unstructured":"Department of Health Philippines (2005). Administrative Order No. 2005\u20132006: Establishment of a Cervical Cancer Screening Program."},{"key":"ref_38","unstructured":"Ngelangel, C.A., Limson, G.M., Ramiro, L.S., Abelardo, A., Avila, J.M., Cordero, C., Delgado, A., Fajutrao, L., Tan-Torres, T., and Banzon, E. (2001, January 28). Delineation of an Appropriate and Replicable Cervical Cancer Screening Program for Filipino Women. Proceedings of the 1st Health Research for Action, Manila, Philippines."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e1115","DOI":"10.1016\/S2214-109X(22)00241-8","article-title":"Cervical Cancer Screening Programmes and Age-Specific Coverage Estimates for 202 Countries and Territories Worldwide: A Review and Synthetic Analysis","volume":"10","author":"Bruni","year":"2022","journal-title":"Lancet Glob. Health"},{"key":"ref_40","unstructured":"WHO (2020). Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem, WHO."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Ho, F.D.V., Arevalo, M.V.P.N., de Claro, P.T.S., Jacomina, L.E., Germar, M.J.V., Dee, E.C., and Eala, M.A.B. (2022). Breast and Cervical Cancer Screening in the Philippines: Challenges and Steps Forward. Prev. Med. Rep., 29.","DOI":"10.1016\/j.pmedr.2022.101936"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2021.10.036","article-title":"Cervical Cancer Burden, Status of Implementation and challenges of Cervical Cancer Screening in Association of Southeast Asian (ASEAN) Countries","volume":"525","author":"Zhao","year":"2022","journal-title":"Cancer Lett."},{"key":"ref_43","unstructured":"Dayrit, M.M., Lagrada, L.P., Picazo, O.F., Pons, M.C., and Villaverde, M.C. (2018). Health Systems in Transition: The Philippines Health System Review, World Health Organization. [2nd ed.]. Regional Office for South-East Asia."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"610798","DOI":"10.3389\/fgene.2020.610798","article-title":"State of the Field in Multi-Omics Research: From Computational Needs to Data Mining and Sharing","volume":"11","author":"Krassowski","year":"2020","journal-title":"Front. Genet."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Kumari Duppala, S., Yadala, R., Velingkar, A., Suravajhala, P., Pawar, S.C., and Vuree, S. (2022). Integrative Multi-Omics Approaches for Identifying Cervical Cancer Therapeutic Targets. bioRxiv.","DOI":"10.1101\/2022.10.07.511244"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/s41416-021-01545-0","article-title":"Multi-Omics Mapping of Human Papillomavirus Integration Sites Illuminates Novel Cervical Cancer Target Genes","volume":"125","author":"Iden","year":"2021","journal-title":"Br. J. Cancer"},{"key":"ref_47","first-page":"1","article-title":"Linking Cervicovaginal Immune Signatures, HPV and Microbiota Composition in Cervical Carcinogenesis in Non-Hispanic and Hispanic Women","volume":"8","author":"Barnes","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ygyno.2015.04.036","article-title":"The Vaginal and Gastrointestinal Microbiomes in Gynecologic Cancers: A Review of Applications in Etiology, Symptoms and Treatment","volume":"138","author":"Chase","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Audirac-Chalifour, A., Torres-Poveda, K., Bahena-Rom\u00e1n, M., T\u00e9llez-Sosa, J., Mart\u00ednez-Barnetche, J., Cortina-Ceballos, B., L\u00f3pez-Estrada, G., Delgado-Romero, K., Burguete-Garc\u00eda, A.I., and Cant\u00fa, D. (2016). Cervical Microbiome and Cytokine Profile at Various Stages of Cervical Cancer: A Pilot Study. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0153274"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"15479","DOI":"10.1038\/s41598-018-33750-y","article-title":"Association of Cervical Microbial Community with Persistence, Clearance and Negativity of Human Papillomavirus in Korean Women: A Longitudinal Study","volume":"8","author":"Arokiyaraj","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Usyk, M., Zolnik, C.P., Castle, P.E., Porras, C., Herrero, R., Gradissimo, A., Gonzalez, P., Safaeian, M., Schiffman, M., and Burk, R.D. (2020). Cervicovaginal Microbiome and Natural History of HPV in a Longitudinal Study. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008376"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/1471-0528.15854","article-title":"The Vaginal Microbiota, Human Papillomavirus and Cervical Dysplasia: A Systematic Review and Network Meta-Analysis","volume":"127","author":"Norenhag","year":"2020","journal-title":"BJOG"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ajog.2018.12.011","article-title":"Vaginal Dysbiosis and the Risk of Human Papillomavirus and cervical Cancer: Systematic Review and Meta-Analysis","volume":"221","author":"Brusselaers","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1053\/j.gastro.2019.11.305","article-title":"Microbial Diversity in Clinical Microbiome Studies: Sample Size and Statistical Power Considerations","volume":"158","author":"Song","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_55","unstructured":"ICO\/IARC Information Centre on HPV and Cancer (2017). Philippines Human Papillomavirus and Related Cancers, Fact Sheet 2017, ICO\/IARC Information Centre on HPV and Cancer."},{"key":"ref_56","unstructured":"Philippe, G. (2022, August 01). Sampsize. Available online: https:\/\/sampsize.sourceforge.net\/iface\/index.html."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"100943","DOI":"10.1016\/j.gore.2022.100943","article-title":"Co-Infection of Human Papillomavirus and Other Sexually Transmitted Bacteria in Cervical Cancer Patients in the Philippines","volume":"40","author":"Tantengco","year":"2022","journal-title":"Gynecol. Oncol. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Baasland, I., Romundstad, P.R., Eide, M.L., and Jonassen, C.M. (2019). Clinical Performance of Anyplex II HPV28 by Human Papillomavirus Type and Viral Load in a Referral Population. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0210997"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1128\/JCM.02749-13","article-title":"Comparison of Seegene Anyplex II HPV28 with the PGMY-CHUV Assay for Human Papillomavirus Genotyping","volume":"52","author":"Estrade","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"ovac002","DOI":"10.1093\/lambio\/ovac002","article-title":"Comparison of Seegene AnyPlexTM II STI-7e with Standard-of-Care Diagnostic Methods for the Detection of Mycoplasma Genitalium, Chlamydia Trachomatis, Neisseria Gonorrhoeae, and Trichomonas Vaginalis","volume":"76","author":"Bodiybadu","year":"2023","journal-title":"Lett. Appl. Microbiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e1134","DOI":"10.1016\/j.ijid.2013.07.011","article-title":"Performance of AnyplexTM II Multiplex Real-Time PCR for the Diagnosis of Seven Sexually Transmitted Infections: Comparison with Currently Available Methods","volume":"17","author":"Choe","year":"2013","journal-title":"Int. J. Infect. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0002-9343(83)91112-9","article-title":"Nonspecific Vaginitis. Diagnostic Criteria and Microbial and Epidemiologic Associations","volume":"74","author":"Amsel","year":"1983","journal-title":"Am. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/jcm.29.2.297-301.1991","article-title":"Reliability of Diagnosing Bacterial Vaginosis Is Improved by a Standardized Method of Gram Stain Interpretation","volume":"29","author":"Nugent","year":"1991","journal-title":"J. Clin. Microbiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1128\/JCM.43.9.4607-4612.2005","article-title":"Utility of Amsel Criteria, Nugent Score, and Quantitative PCR for Gardnerella Vaginalis, Mycoplasma Hominis, and Lactobacillus Spp. for Diagnosis of Bacterial Vaginosis in Human Immunodeficiency Virus-Infected Women","volume":"43","author":"Sha","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Khan, I., Nam, M., Kwon, M., Seo, S.-S., Jung, S., Han, J.S., Hwang, G.-S., and Kim, M.K. (2019). LC\/MS-Based Polar Metabolite Profiling Identified Unique Biomarker Signatures for Cervical Cancer and Cervical Intraepithelial Neoplasia Using Global and Targeted Metabolomics. Cancers, 11.","DOI":"10.3390\/cancers11040511"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"106399","DOI":"10.1016\/j.ypmed.2020.106399","article-title":"HPV Vaccination Introduction Worldwide and WHO and UNICEF of National HPV Immunization Coverage 2010\u20132019","volume":"144","author":"Bruni","year":"2021","journal-title":"Prev. Med."},{"key":"ref_67","unstructured":"World Health Organization (2022, August 01). Human Papillomavirus (HPV) Vaccination Coverage. Available online: https:\/\/immunizationdata.who.int\/pages\/coverage\/hpv.html."},{"key":"ref_68","unstructured":"World Health Organization (2022, August 01). Regional Office for South-East Asia. Accelerating the Elimination of Cervical Cancer as a Global Public Health Problem. World Health Organization. Regional Office for South-East Asia. Available online: https:\/\/apps.who.int\/iris\/handle\/10665\/327911."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.13484","article-title":"WHO Global Strategy to Eliminate Cervical Cancer as a Public Health Problem: An Opportunity to Make It a Disease of the Past","volume":"152","author":"Simelela","year":"2021","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_70","unstructured":"Department of Health (2022, October 01). Department Memorandum No. 2015-0316: Guidelines in the Implementation of Human Papillomavirus (HPV) Vaccination, Available online: https:\/\/doh.gov.ph\/sites\/default\/files\/health_programs\/DM%202015-0316%20Guidelines%20in%20the%20Implementation%20of%20HPV%20Vaccination_0.pdf."},{"key":"ref_71","unstructured":"Philippine Statistics Authority (2022, October 01). Health Spending Registered 12.6 Percent Growth, Share of Health to Economy Went Up to 5.6 Percent in 2020. Philippine Statistics Authority Reference Number: 2021-427, Available online: https:\/\/psa.gov.ph\/pnha-press-release\/node\/165216."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pvr.2017.04.003","article-title":"Projected Impact of HPV Vaccination and Primary HPV Screening on Cervical Adenocarcinoma: Example from Australia","volume":"3","author":"Smith","year":"2017","journal-title":"Papillomavirus Res."},{"key":"ref_73","unstructured":"(2022, December 01). Launch of SUCCESS Project in the Philippines Intensifies Fight against Cervical Cancer. Available online: https:\/\/Ph.Ambafrance.Org\/Launch-of-SUCCESS-Project-in-the-Philippines-Intensifies-Fight-against-Cervical."},{"key":"ref_74","unstructured":"World Health Organization (2022). Regional Office for South-East Asia Accelerating the Elimination of Cervical Cancer as a Public Health Problem: Towards Achieving 90\u201370\u201390 Targets by 2030, World Health Organization."}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/11\/5\/658\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:40:38Z","timestamp":1760121638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/11\/5\/658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":74,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["healthcare11050658"],"URL":"https:\/\/doi.org\/10.3390\/healthcare11050658","relation":{},"ISSN":["2227-9032"],"issn-type":[{"value":"2227-9032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,23]]}}}